Overview
Lisa Derosa practices in Villejuif, France. Ms. Derosa is rated as an Elite expert by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Non-Small Cell Lung Cancer (NSCLC), and Lung Cancer.
Her clinical research consists of co-authoring 122 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 32 articles in the study of Renal Cell Carcinoma (RCC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Renal Cell Carcinoma (RCC)Ms. Derosa isElite. Learn about Renal Cell Carcinoma (RCC).
- Advanced
- Lung CancerMs. Derosa isAdvanced. Learn about Lung Cancer.
- Neuroendocrine TumorMs. Derosa isAdvanced. Learn about Neuroendocrine Tumor.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Bladder CancerMs. Derosa isExperienced. Learn about Bladder Cancer.
- Bone TumorMs. Derosa isExperienced. Learn about Bone Tumor.
- Breast CancerMs. Derosa isExperienced. Learn about Breast Cancer.
- Chromophobe Renal Cell CarcinomaMs. Derosa isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Colorectal CancerMs. Derosa isExperienced. Learn about Colorectal Cancer.
- COVID-19Ms. Derosa isExperienced. Learn about COVID-19.